VANCOUVER, BC, Oct. 25, 2021 /CNW/ – HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life“) announces the departure of Mr. Rick Brar as Vice-Chair of the board of directors of the Company (“Board“) and as a director of the Company, effective immediately. The Company expresses its appreciation for Mr. Brar’s services to the Company and wishes him well in his…


Previous articleMindMed CMO to Chair Digital Biomarkers Summit
Next articleMindMed Expands its Drug Development Pipeline with Launch of R(-)-MDMA Program